预防性人乳头瘤病毒(human papilloma virus,HPV)疫苗接种是预防HPV感染的有效方法,可降低HPV感染相关疾病的发生。目前国内外临床试验及真实世界研究均表明,预防性HPV疫苗接种是安全的,具有很好的免疫原性、保护效力和保护效果。优先推荐9~26岁女性接种HPV疫苗,重点是9~14岁女孩;同时,推荐27~45岁女性和9~26 ...

2025年1月19日，中国江西南昌市的一家医院，男性排队接种HPV四价疫苗。摄：Liu Lixin/China News Service/VCG via Getty Images 现在不差钱了. 在很长一段时间内，一个疫苗能否纳入中国国家免疫规划免费接种的最重要的影响因素是财政问题。

1 天前 · 2025年1月19日，中國江西南昌市的一家醫院，男性排隊接種HPV四價疫苗。攝：Liu Lixin/China News Service/VCG via Getty Images 現在不差錢了. 在很長一段時間內，一個疫苗能否納入中國國家免疫規劃免費接種的最重要的影響因素是財政問題。

2025年1月15日 · In China, the prevalence and impact of HPV and cervical cancer have garnered increasing attention due to its substantial burden on public health. This chapter provides an in-depth exploration of the incidence, prevalence, risk factors, screening methods, prevention strategies, and challenges associated with HPV and cervical cancer in China.

China has a high burden of human papillomaviruses (HPV)-related cancers, with the second highest incidence and mortality rate of cervical cancer worldwide. Financial constraints, regional restrictions and gender-specific vaccination policies have led to disparities in HPV vaccination rates across China.

2023年9月21日 · For more than 15 years, China has expedited a series of efforts on research and development of the domestically manufactured HPV vaccines, producing local population-based evidence, promoting free HPV vaccination from pilots, and launching action plans to tackle barriers in the scale-up of HPV vaccination.

2023年11月10日 · The incidence and mortality rates of cervical cancer in China rank second globally, while the HPV vaccination coverage remains as low as 3%, highlighting an urgent need for enhanced immunization coverage.

2025年3月13日 · Background: Cervical cancer (CC), primarily caused by human papillomavirus (HPV) infection, remains a significant global health concern. We aimed to comprehensively investigate the epidemiological status of HPV in China. Methods: Data from 2,728,321 women undergoing routine cervical examinations at 2127 medical institutions nationwide from January 2017 to June 2023 were analyzed.

2025年3月5日 · In China, Cervical cancer is one of the common malignant tumors in females, and high-risk human papillomavirus (HR-HPV) infection is one of its main causative factors. However, human papillomavirus (HPV) infection rates may vary significantly among patients of different ages and HPV subtypes. This study aims to provide insights into developing cervical cancer screening strategies and selecting ...

2024年5月10日 · In this study, we aimed to estimate the provincial-level HPV coverage among females aged 9–45 years old in China from 2017 to 2022. Additionally, we estimated the coverage among Chinese females by age group specifically for the year 2022.